Company Description
Bigmar, Inc.. The Group's principal activity is to manufacture and market generic pharmaceutical Oncology products and intravenous infusion solutions. It operates through three wholly owned subsidiaries: Bioren SA (Bioren), Bigmar Pharmaceuticals SA ...
More
Related Business Topics
